GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM47197
Query DataSets for GSM47197
Status
Public on Nov 11, 2005
Title
palisading 4
Sample type
RNA
Source name
human glioblastoma
Organism
Homo sapiens
Extracted molecule
total RNA
Description
specific tumor cell type-pseudopalisading cells in human glioblastoma, case 2
Submission date
Apr 04, 2005
Last update date
Nov 10, 2005
Contact name
Shumin Dong
E-mail(s)
[email protected]
Phone
617 726 5510
Fax
617 726 5677
Organization name
Massachusetts General Hospital
Department
Pathology and Neurosurgical services
Lab
Molecular Neuro-Oncology lab
Street address
149# 13th ST
City
Charlestown
State/province
MA
ZIP/Postal code
02129
Country
USA
Platform ID
GPL96
Series (1)
GSE2485
Gene expression of pseudopalisading cells in human glioblastoma
Data table header descriptions
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
109.6
P
0.000258
AFFX-BioB-M_at
317.6
P
0.000081
AFFX-BioB-3_at
148.1
P
0.000095
AFFX-BioC-5_at
318.7
P
0.00007
AFFX-BioC-3_at
232.4
P
0.00006
AFFX-BioDn-5_at
310.2
P
0.000052
AFFX-BioDn-3_at
1415.6
P
0.000052
AFFX-CreX-5_at
3094
P
0.000044
AFFX-CreX-3_at
3428.3
P
0.000044
AFFX-DapX-5_at
13.3
A
0.131361
AFFX-DapX-M_at
4.2
A
0.48511
AFFX-DapX-3_at
1.4
A
0.368438
AFFX-LysX-5_at
3.9
A
0.574038
AFFX-LysX-M_at
11.8
A
0.52976
AFFX-LysX-3_at
1.7
A
0.876428
AFFX-PheX-5_at
0.8
A
0.960339
AFFX-PheX-M_at
2.5
A
0.724854
AFFX-PheX-3_at
5
A
0.672921
AFFX-ThrX-5_at
14.3
A
0.227636
AFFX-ThrX-M_at
8.3
A
0.440646
Total number of rows:
22283
Table truncated, full table size
574 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM47197.CEL.gz
3.3 Mb
(ftp)
(http)
CEL
GSM47197.EXP.gz
460 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|